Rock, Crosby
Sood, Sumit
Cao, Ying
Shelton, Shary
Chen, Ronald C.
Wang, Fen
Article History
Received: 5 January 2023
Accepted: 15 June 2023
First Online: 2 August 2023
Declarations
:
: This study was retrospective in nature. All acquired patient specific data was kept anonymized. The University of Kansas Institutional Review Board approved this study.
: I, Fen Wang, declare that I have read the final version of the article “Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity”, and give my consent for publication in the journal Radiation Oncology.
: The author’s declared that they have no competing interests.